Unknown

Dataset Information

0

The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.


ABSTRACT: Epstein-Barr virus (EBV), which infects not only B cells but also T and natural killer (NK) cells, is associated with a variety of lymphoid malignancies. Because EBV-associated T and NK cell lymphomas are refractory and resistant to conventional chemotherapy, there is a continuing need for new effective therapies. EBV-encoded "latent membrane protein 1" (LMP1) is a major oncogene that activates nuclear factor kappa B (NF-?B), c-Jun N-terminal kinase (JNK), and phosphatidylinositol 3-kinase signaling pathways, thus promoting cell growth and inhibiting apoptosis. Recently, we screened a library of small-molecule inhibitors and isolated heat shock protein 90 (Hsp90) inhibitors as candidate suppressors of LMP1 expression. In this study, we evaluated the effects of BIIB021, a synthetic Hsp90 inhibitor, against EBV-positive and -negative T and NK lymphoma cell lines. BIIB021 decreased the expression of LMP1 and its downstream signaling proteins, NF-?B, JNK, and Akt, in EBV-positive cell lines. Treatment with BIIB021 suppressed proliferation in multiple cell lines, although there was no difference between the EBV-positive and -negative lines. BIIB021 also induced apoptosis and arrested the cell cycle at G1 or G2. Further, it down-regulated the protein levels of CDK1, CDK2, and cyclin D3. Finally, we evaluated the in vivo effects of the drug; BIIB021 inhibited the growth of EBV-positive NK cell lymphomas in a murine xenograft model. These results suggest that BIIB021 has suppressive effects against T and NK lymphoma cells through the induction of apoptosis or a cell cycle arrest. Moreover, BIIB021 might help to suppress EBV-positive T or NK cell lymphomas via the down-regulation of LMP1 expression.

SUBMITTER: Suzuki M 

PROVIDER: S-EPMC4391044 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.

Suzuki Michio M   Takeda Tadashi T   Nakagawa Hikaru H   Iwata Seiko S   Watanabe Takahiro T   Siddiquey Mohammed N A MN   Goshima Fumi F   Murata Takayuki T   Kawada Jun-Ichi J   Ito Yoshinori Y   Kojima Seiji S   Kimura Hiroshi H  

Frontiers in microbiology 20150409


Epstein-Barr virus (EBV), which infects not only B cells but also T and natural killer (NK) cells, is associated with a variety of lymphoid malignancies. Because EBV-associated T and NK cell lymphomas are refractory and resistant to conventional chemotherapy, there is a continuing need for new effective therapies. EBV-encoded "latent membrane protein 1" (LMP1) is a major oncogene that activates nuclear factor kappa B (NF-κB), c-Jun N-terminal kinase (JNK), and phosphatidylinositol 3-kinase signa  ...[more]

Similar Datasets

| S-EPMC8673718 | biostudies-literature
| S-EPMC7718318 | biostudies-literature
| S-EPMC8649941 | biostudies-literature
| S-EPMC4813586 | biostudies-literature
| S-EPMC5949068 | biostudies-literature
| S-EPMC7465148 | biostudies-literature
| S-EPMC5045423 | biostudies-literature
| S-EPMC9264932 | biostudies-literature
| S-EPMC4547841 | biostudies-literature
| S-EPMC3000965 | biostudies-literature